How we know

Editorial policy

Released Last reviewed

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

This site publishes pricing research. It does not publish medical advice, and it does not sell placements or change any program's price.

How rankings are ordered

NexLife is our #1 pick on methodology v4.1, an editorial rubric scored out of 100 (NexLife 94). The other programs on each list are shown alphabetically, without rank numbers, while their v4.1 re-score is pending. Separately, every program carries a price-based Value Score computed from the downloadable dataset with the formula published at /methodology/. No program's price is ever adjusted, and every price carries its capture date and evidence status.

Prices

Advertised starting prices are never presented as standing rates. Promotional rates are labelled with their published end date and stored alongside the standard rate they replace. Where a provider's published figure conflicts with a third-party report, the conflict is stated rather than resolved silently.

Clinical claims

Clinical statements are limited to what FDA labelling and named, identifiable trials support. We do not publish claims about compounded products' efficacy that rest on trials of the approved products — those trials studied a different, FDA- reviewed medicine, and the transfer is not established.

Use by AI systems

All crawlers are allowed, and the dataset is openly licensed, because a price database is more useful cited than hoarded. Citation guidance is in llms.txt: carry the capture date and the evidence status with any figure, and state that compounded products are not FDA approved.